AIXC
AIxCrypto Holdings, Inc.
NASDAQ · Healthcare · Medical - Pharmaceuticals · US
$0.71
+1.91%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | 12.2K |
| Gross Profit | — | — | — | — | (12.2K) |
| Operating Expenses | |||||
| R&D Expense | 144.0K | 184.8K | 1.2M | 5.2M | 4.5M |
| SG&A Expense | 12.1M | 8.8M | 4.2M | 6.1M | 10.3M |
| General & Admin Expense | 8.5M | 8.8M | 4.2M | 6.1M | 10.3M |
| Selling & Marketing Expense | 638.2K | — | — | — | — |
| Other Expenses | 3.9M | 4.2M | 360.0K | — | (12.2K) |
| Total Operating Expenses | 16.1M | 13.2M | 5.8M | 11.3M | 14.7M |
| Cost and Expenses | 16.1M | 13.2M | 5.8M | 11.3M | 14.8M |
| Operating Income (EBIT) | (16.1M) | (13.2M) | (5.8M) | (11.3M) | (14.8M) |
| Non-Operating | |||||
| Interest Income | 916.6K | 742.0K | 128.8K | — | — |
| Interest Expense | 808.8K | 988.5K | 908.9K | 1.5M | 34.4K |
| Net Interest Income | 107.7K | (246.5K) | (780.1K) | (1.5M) | (34.4K) |
| Other Non-Op Income/Expense | (6.8M) | (3.8M) | (391.1K) | (1.2M) | 872.8K |
| Non-Operating Income (excl Interest) | 4.8M | 2.8M | (517.8K) | (349.8K) | (907.2K) |
| EBT (Pre-Tax Income) | (22.9M) | (17.0M) | (6.2M) | (12.5M) | (13.9M) |
| Income Tax Expense | (35.00) | — | 6.3K | (4.8K) | 6.5K |
| Bottom Line | |||||
| Net Income | (22.9M) | (17.0M) | (6.3M) | (13.4M) | (18.6M) |
| Earnings from Cont. Ops | (22.9M) | (17.0M) | (6.2M) | (12.5M) | (13.9M) |
| Earnings from Discont. Ops | — | — | (100.0K) | (1.3M) | (7.1M) |
| Bottom Line Net Income | (25.5M) | (19.5M) | (6.3M) | (13.4M) | (18.6M) |
| Per Share | |||||
| Basic EPS | ($9.44) | ($8.11) | ($17.55) | ($132.25) | ($243.00) |
| Diluted EPS | ($6.49) | ($8.11) | ($17.55) | ($132.25) | ($243.00) |
| Revenue Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Shares | |||||
| Basic Shares Outstanding | 20.3M | 2.4M | 361587 | 101454 | 76806 |
| Diluted Shares Outstanding | 20.3M | 2.4M | 361587 | 101454 | 76806 |
| Profitability Metrics | |||||
| EBITDA | (20.9M) | (16.0M) | (5.2M) | (11.0M) | (13.8M) |
| D&A | — | — | — | 4.5K | 12.2K |
| EBIT | (20.9M) | (16.0M) | (5.2M) | (11.0M) | (13.9M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026